FdaApplication
NDA 010040
Identifiers
- fda_app_no: NDA010040
Properties
| Property | Value |
|---|---|
| applicant_name | BRACCO DIAGNOSTICS INC |
| application_type | NDA |
| approval_date | 1982-11-09 |
Products (10)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CYSTOGRAFIN | DIATRIZOATE MEGLUMINE | 30% | SOLUTION;URETHRAL |
| CYSTOGRAFIN DILUTE | DIATRIZOATE MEGLUMINE | 18% | SOLUTION;URETHRAL |
| DIATRIZOATE MEGLUMINE | DIATRIZOATE MEGLUMINE | 76% | INJECTABLE;INJECTION |
| RENO-30 | DIATRIZOATE MEGLUMINE | 30% | SOLUTION;URETERAL |
| RENO-60 | DIATRIZOATE MEGLUMINE | 60% | INJECTABLE;INJECTION |
| RENO-DIP | DIATRIZOATE MEGLUMINE | 30% | INJECTABLE;INJECTION |
| RENOGRAFIN-60 | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | 52%;8% | INJECTABLE;INJECTION |
| RENOGRAFIN-76 | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | 66%;10% | INJECTABLE;INJECTION |
| RENOVIST | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | 34.3%;35% | INJECTABLE;INJECTION |
| RENOVIST II | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | 28.5%;29.1% | INJECTABLE;INJECTION |
10 products